No, a CT Pulmonary Angiogram Does Not Indicate Concern for ALS
A CT pulmonary angiogram (CTPA) has no diagnostic value for amyotrophic lateral sclerosis (ALS) and should not raise or alleviate concerns about this disease. CTPA is designed to evaluate the pulmonary vasculature for thromboembolic disease, not neurodegenerative conditions 1.
Why CTPA Is Irrelevant to ALS Diagnosis
ALS Is a Clinical and Electrophysiologic Diagnosis
- ALS diagnosis relies on clinical presentation and electromyography (EMG), not imaging studies 1.
- Patients typically present with hypertonicity, hyperreflexia (upper motor neuron signs), muscle fasciculations, weakness, and atrophy (lower motor neuron signs) 1.
- Electromyography and nerve conduction velocity are the key diagnostic tests for confirming ALS 1.
Imaging Role in ALS Is Limited to Exclusion
- Imaging in suspected ALS is used mainly to exclude other conditions that mimic the clinical presentation, not to confirm the diagnosis 1.
- MRI of the brain and spine without IV contrast is the appropriate imaging modality when neuroimaging is indicated for suspected motor neuron disease 1.
- CT has limited utility in ALS evaluation due to poor soft-tissue characterization compared to MRI 1.
CTPA Evaluates Completely Different Pathology
- CTPA is specifically designed to detect pulmonary embolism by visualizing thrombi in the pulmonary arterial tree 2, 3, 4.
- The study evaluates vascular filling defects, right ventricular strain, and pulmonary parenchymal abnormalities related to thromboembolic disease 2, 3, 4.
- There is no overlap between CTPA findings and ALS pathophysiology, which involves motor neuron degeneration in the brain and spinal cord 1, 5, 6.
When to Actually Suspect ALS
Clinical Red Flags Requiring Evaluation
- Progressive muscle weakness affecting limbs or bulbar muscles (speech, swallowing) 5, 7, 6.
- Combination of upper and lower motor neuron signs on neurological examination 1, 6.
- Muscle fasciculations, atrophy, and hyperreflexia without sensory deficits 1, 6.
- Respiratory muscle weakness manifesting as dyspnea, orthopnea, or reduced vital capacity 5, 6, 8.
Appropriate Diagnostic Workup for ALS Concerns
- Referral to neurology for comprehensive neurological examination 7.
- EMG and nerve conduction studies to document motor neuron involvement 1.
- Pulmonary function tests (PFTs) including forced vital capacity (FVC), which correlates with survival and respiratory muscle involvement 9.
- MRI brain and/or spine without contrast only if needed to exclude structural lesions or alternative diagnoses 1.
Common Pitfall to Avoid
Do not conflate respiratory symptoms with ALS based on imaging alone. While ALS ultimately causes respiratory failure as the most common cause of death 5, 6, 8, this occurs through progressive respiratory muscle weakness, not through pulmonary vascular or parenchymal disease detectable on CTPA 5, 6. If your CTPA was performed for dyspnea or respiratory symptoms, these symptoms have numerous potential causes unrelated to ALS, and the CTPA results address vascular etiologies specifically 2, 3.